{"gene":"SKIL","run_date":"2026-06-10T07:46:32","timeline":{"discoveries":[{"year":1999,"finding":"SnoN directly interacts with Smad2 and Smad4, represses their transcriptional activity through recruitment of the transcriptional corepressor N-CoR, and maintains the repressed state of TGF-β-responsive genes in the absence of ligand. Upon TGF-β stimulation, Smad3 nuclear accumulation leads to rapid SnoN degradation, allowing target gene activation; by 2 hours, TGF-β induces SnoN re-expression to terminate Smad-mediated transactivation (negative feedback).","method":"Co-immunoprecipitation, transcriptional reporter assays, Western blotting","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP and functional reporter assays, replicated in multiple subsequent studies","pmids":["10531062"],"is_preprint":false},{"year":1999,"finding":"Smad3 associates with SnoN in the nucleus; overexpression of SnoN represses Smad3-mediated transcriptional activation. TGF-β stimulation leads to rapid, proteasome-mediated degradation of SnoN.","method":"Co-immunoprecipitation, transcriptional reporter assay, proteasome inhibitor treatment","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP plus functional assay plus pharmacological evidence, independently replicated","pmids":["10535941"],"is_preprint":false},{"year":2001,"finding":"TGF-β induces assembly of a Smad2–Smurf2 ubiquitin ligase complex that targets SnoN for ubiquitin-mediated proteasomal degradation. Smad2 interacts with Smurf2 via its PPXY motif and WW domains, and Smad2 mediates the interaction of Smurf2 with SnoN.","method":"Co-immunoprecipitation, ubiquitination assay, proteasome inhibitor treatment","journal":"Nature Cell Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — biochemical reconstitution of the complex, multiple orthogonal methods, replicated by independent labs","pmids":["11389444"],"is_preprint":false},{"year":2001,"finding":"Smad3 (and to a lesser extent Smad2) recruits the anaphase-promoting complex (APC) with UbcH5 ubiquitin-conjugating enzymes to SnoN, causing ubiquitination at a destruction box (D box) and proteasomal degradation of SnoN. Mutation of the Smad3-binding site or key lysine residues in SnoN stabilizes it and enhances antagonism of TGF-β signaling.","method":"In vitro ubiquitination assay, co-immunoprecipitation, mutagenesis, proteasome inhibitor treatment","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro ubiquitination reconstitution with mutagenesis, replicated by independent lab (PMID 11741538)","pmids":["11691834","11741538"],"is_preprint":false},{"year":2001,"finding":"The APC activator CDH1 forms a quaternary complex with SnoN, Smad3, and APC to mediate SnoN destruction in response to TGF-β. The destruction box of SnoN is required for its degradation.","method":"Co-immunoprecipitation, ubiquitination assay, mutagenesis","journal":"Molecular Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — biochemical complex reconstitution and mutagenesis, consistent with independent study (PMID 11691834)","pmids":["11741538"],"is_preprint":false},{"year":2003,"finding":"Smad2 and Smad3 bind to distinct regions of SnoN; mutation of both Smad-binding regions (but not individually) impairs SnoN-mediated repression of TGF-β transcription and cell cycle arrest. Mutant SnoN defective in Smad binding fails to induce oncogenic transformation, demonstrating that transforming activity requires Smad repression.","method":"Mutagenesis, co-immunoprecipitation, transcriptional reporter assay, transformation assay","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic mutagenesis with multiple functional readouts in single lab","pmids":["12764135"],"is_preprint":false},{"year":2005,"finding":"In normal tissues and non-tumorigenic epithelial cells, SnoN is predominantly cytoplasmic and antagonizes TGF-β signaling by sequestering Smad proteins in the cytoplasm rather than by nuclear transcriptional repression. Cytoplasmic SnoN is resistant to TGF-β-induced degradation. Upon differentiation or cell-cycle arrest, SnoN translocates to the nucleus.","method":"Subcellular fractionation, immunofluorescence, functional TGF-β signaling assays","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 / Moderate — fractionation plus functional assays with multiple cell types, single lab","pmids":["16109768"],"is_preprint":false},{"year":2006,"finding":"Cdh1-APC forms a physical complex with SnoN in neurons and stimulates ubiquitin-dependent proteasomal degradation of SnoN. SnoN promotes axonal growth downstream of Cdh1-APC; SnoN knockdown reduces axonal growth and suppresses Cdh1 RNAi-induced axonal enhancement. SnoN is required for cerebellar granule neuron parallel fiber development in vivo.","method":"Co-immunoprecipitation, RNAi knockdown, in vivo cerebellar electroporation, axon length quantification","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, genetic epistasis, in vivo knockdown with defined phenotype, replicated in follow-up studies","pmids":["16675394"],"is_preprint":false},{"year":2006,"finding":"SnoN is sumoylated primarily at lysine residues 50 and 383. The SUMO E2 enzyme Ubc9 is critical for this modification and SUMO E3 ligase PIAS1 selectively interacts with and enhances SnoN sumoylation. Sumoylation of SnoN augments its ability to repress gene expression in a promoter-specific manner, particularly suppressing myogenin transcription.","method":"In vivo sumoylation assay, mutagenesis (K50R, K383R), co-immunoprecipitation, transcriptional reporter assay","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — site-directed mutagenesis identifying SUMO acceptor sites, functional assays, replicated by independent lab (PMID 17202138)","pmids":["16966324","17202138"],"is_preprint":false},{"year":2007,"finding":"Arkadia (RNF111), an E3 ubiquitin ligase, interacts with SnoN, induces its ubiquitination, and is essential for TGF-β-induced SnoN degradation. SnoN is efficiently degraded only when it forms a complex with both Arkadia and phosphorylated Smad2 or Smad3. Arkadia is required for Smad3/Smad4-dependent transcription but not for Smad1/Smad4 or Smad2/Smad4/FoxH1-dependent responses.","method":"siRNA library screen, co-immunoprecipitation, ubiquitination assay, transcriptional reporter assay, dominant-negative mutant","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods, confirmed in independent lab (PMID 17510063)","pmids":["17591695","17510063"],"is_preprint":false},{"year":2007,"finding":"TAK1 (MAP3K7) interacts with and phosphorylates SnoN; this phosphorylation destabilizes SnoN. Inactivation of TAK1 prevents TGF-β-induced SnoN degradation and impairs induction of TGF-β-responsive genes.","method":"Co-immunoprecipitation, in vitro kinase assay, TAK1 dominant-negative/knockdown, Western blotting","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinase assay plus functional consequence, single lab","pmids":["17276978"],"is_preprint":false},{"year":2007,"finding":"SnoN sumoylation at lysine 50 is regulated by PIAS1 and PIASx as SUMO E3 ligases. Loss of sumoylation (K50R mutation) potently activates muscle-specific gene expression and enhances myotube formation. Sumoylation does not alter SnoN stability or its ability to repress TGF-β signaling but specifically controls myogenic differentiation.","method":"In vivo sumoylation assay, mutagenesis, myotube formation assay, gene expression analysis","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — site-directed mutagenesis with clear functional phenotype, consistent with PMID 16966324","pmids":["17202138"],"is_preprint":false},{"year":2008,"finding":"In neurons, TGFβ-regulated Smad2 is phosphorylated and localized in the nucleus where it forms a physical complex with endogenous SnoN. Smad2 knockdown stimulates axonal growth. Epistasis analyses show Smad2 acts upstream of SnoN in the Cdh1-APC pathway controlling axonal morphogenesis.","method":"Co-immunoprecipitation of endogenous proteins, RNAi knockdown, genetic epistasis, axon length measurement","journal":"Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — endogenous protein Co-IP, multiple knockdown approaches, genetic epistasis establishing pathway order","pmids":["18287512"],"is_preprint":false},{"year":2009,"finding":"SnoN interacts with the coactivator p300 in neurons, and p300 is required for SnoN-induced axon growth. SnoN transcriptionally activates the Ccd1 gene; Ccd1 localizes to the actin cytoskeleton at axon terminals, activates JNK, and is required for SnoN-dependent axonal growth in vivo.","method":"Co-immunoprecipitation, gene profiling, RNAi knockdown, in vivo cerebellar electroporation","journal":"Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, transcriptional target identification, genetic epistasis, in vivo knockdown","pmids":["19339625"],"is_preprint":false},{"year":2009,"finding":"High levels of SnoN induce premature senescence by a Smad-independent mechanism: SnoN interacts with PML protein, is recruited to PML nuclear bodies, and stabilizes p53. SnoN overexpression inhibits oncogenic transformation by Ras and Myc and blocks papilloma development in vivo.","method":"Co-immunoprecipitation, PML nuclear body immunofluorescence, p53 stability assay, in vivo carcinogenesis model","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, functional localization to PML bodies, in vivo tumor suppressor phenotype with multiple methods","pmids":["19745809"],"is_preprint":false},{"year":2010,"finding":"SnoN acts as a master repressor of ADAM12 gene expression in response to TGF-β1 stimulation. SnoN overexpression reduces TGF-β1-induced ADAM12 induction; SnoN shRNA knockdown enhances it. This repression is Smad2/Smad3-dependent and occurs via derepression of the Adam12 gene.","method":"shRNA knockdown, overexpression, mRNA/protein analysis, Smad2/3 dependence assay","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain and loss of function with defined molecular target, single lab","pmids":["20457602"],"is_preprint":false},{"year":2011,"finding":"SnoN interacts with the estrogen-activated form of ERα in the nucleus via conserved LxxLL-like motifs. SnoN overexpression enhances ERα transcriptional activity at ERE-reporter and target genes; SnoN knockdown reduces it. SnoN supports p300 recruitment to the ERα target gene TTF1 promoter.","method":"Co-immunoprecipitation, LxxLL mutagenesis, chromatin immunoprecipitation, transcriptional reporter assay","journal":"Cellular Signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with mutagenesis and ChIP, single lab","pmids":["22227247"],"is_preprint":false},{"year":2012,"finding":"The SNON-SMAD4 complex binds the SKIL gene promoter via a TGF-β response element (containing SMAD-binding elements) and negatively regulates basal SKIL gene expression by recruiting histone deacetylases, forming a negative feedback loop. Upon TGF-β signaling, SNON is removed from the promoter, allowing activated SMAD complexes to induce SKIL expression.","method":"ChIP, sequential ChIP, promoter cloning, luciferase reporter assay, HDAC recruitment assay","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — ChIP plus sequential ChIP showing SNON-SMAD4 occupancy, functional reporter assay with multiple methods in single lab","pmids":["22674574"],"is_preprint":false},{"year":2012,"finding":"In human embryonic stem cells, SNON predominantly associates with SMAD2 at the promoters of primitive streak and early definitive endoderm marker genes to repress them. SNON knockdown causes premature activation of PS and DE genes and loss of hESC morphology; enforced SNON expression inhibits DE formation and diverts hESCs toward extraembryonic fate.","method":"ChIP, RNAi knockdown, overexpression, gene expression analysis","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP demonstrating promoter occupancy, reciprocal gain/loss of function with clear developmental phenotypes","pmids":["23154981"],"is_preprint":false},{"year":2012,"finding":"SnoN promotes Stat5 stability and signaling in mammary epithelial cells. SnoN expression is induced at late pregnancy by coordinated TGF-β and prolactin actions. SnoN-/- mice show severe alveologenesis and lactogenesis defects rescued by active Stat5, placing SnoN upstream of Stat5 in a TGF-β/prolactin-coordinating pathway.","method":"Knockout mouse model, rescue experiment with active Stat5, co-immunoprecipitation, Stat5 stability assay","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with in vivo phenotype, rescue experiment establishing epistasis, Co-IP","pmids":["22833129"],"is_preprint":false},{"year":2012,"finding":"SnoN suppresses BMP signaling (ID1 expression) in chondrocytes in a TGF-β-induced manner downstream of Smad2 phosphorylation, but upstream of BMP-regulated Smad1/5/8 activation; this mediates TGF-β cross-inhibition of BMP-driven hypertrophic chondrocyte maturation (Col10a1 expression).","method":"siRNA knockdown, overexpression, luciferase reporter assay, pharmacological inhibitor (SB431542)","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain and loss of function with pathway placement, single lab","pmids":["22767605"],"is_preprint":false},{"year":2013,"finding":"SnoN directly binds to ALK1 on the plasma membrane in endothelial cells and facilitates the interaction between ALK1 and Smad1/5, enhancing Smad1/5 phosphorylation and promoting angiogenesis. Disruption of the SnoN-Smad interaction impairs Smad1/5 activation, up-regulates Smad2/3 activity, causes arteriovenous malformations, and leads to embryonic lethality at E12.5.","method":"Co-immunoprecipitation, mutagenesis, conditional knockout mouse model, phospho-Smad assays","journal":"Journal of Cell Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — endogenous protein Co-IP, mutagenesis, in vivo KO with defined vascular phenotype and epistasis","pmids":["24019535"],"is_preprint":false},{"year":2016,"finding":"SnoN interacts with multiple components of the Hippo pathway and inhibits the binding of Lats2 to TAZ, preventing TAZ phosphorylation and promoting TAZ stabilization. SnoN enhances transcriptional and oncogenic activities of TAZ; reducing SnoN decreases TAZ expression. SnoN itself is downregulated by Lats2 activated by the Scribble polarity protein.","method":"Co-immunoprecipitation, kinase assay, knockdown/overexpression, TAZ phosphorylation assay","journal":"Developmental Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, kinase-substrate relationship, bidirectional regulatory relationship established","pmids":["27237790"],"is_preprint":false},{"year":2017,"finding":"Crystal structure of the SAND domain of SnoN in complex with the MH2 domain of SMAD4 was determined, showing a binding mode compatible with simultaneous coordination of R-SMADs. SnoN forms a stable complex with SMAD3 and SMAD4, and this complex formation is distinct from Ski, which disrupts R-SMAD/Co-SMAD heteromers.","method":"X-ray crystallography, biochemical co-purification, stability assay","journal":"Scientific Reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with functional validation, single lab","pmids":["28397834"],"is_preprint":false},{"year":2010,"finding":"Crystal structure of the Dachshund homology domain of human SnoN was determined, revealing a conserved groove with properties of a protein-interaction surface showing conformational flexibility (open and tight conformations), suggesting SnoN can recognize multiple interaction partners.","method":"X-ray crystallography","journal":"PLoS One","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — crystal structure without biochemical or mutagenesis functional validation of the groove","pmids":["20957027"],"is_preprint":false},{"year":2018,"finding":"SnoN promotes mesenchymal stem cell differentiation into the adipocyte lineage by antagonizing activin A/Smad2 (but not TGF-β/Smad3) signaling. Mice lacking SnoN or expressing a SnoN mutant defective in Smad binding are protected from high-fat diet-induced obesity. SnoN represses activin A expression through an autocrine mechanism in adipocytes.","method":"Conditional knockout mouse, high-fat diet model, MSC differentiation assay, Smad-binding mutant","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo KO with specific phenotype, mutagenesis establishing Smad-binding requirement, pathway specificity defined","pmids":["30030373"],"is_preprint":false},{"year":2018,"finding":"Conditional knockout of SnoN in cerebellar granule neuron precursors inhibits their proliferation and promotes cell cycle exit at later postnatal stages. SnoN promotes expression of cell proliferation genes and represses differentiation genes in vivo. SnoN physically interacts with N-myc and Pax6 transcription factors.","method":"Conditional KO, laser capture microdissection/RNA-Seq, Co-immunoprecipitation, behavioral analysis","journal":"Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with genomic profiling and Co-IP identifying novel interaction partners, in vivo behavioral phenotype","pmids":["30425119"],"is_preprint":false},{"year":2021,"finding":"Quantitative ubiquitylome proteomics established that RNF111/Arkadia E3 ubiquitin ligase specifically ubiquitylates SKI and SKIL/SnoN (and no other substrates) upon TGF-β activation. Lysine 343 within the SAND domain of SKIL is identified as the principal ubiquitylation site targeted by RNF111.","method":"Quantitative ubiquitylome mass spectrometry (diGly remnant immunoprecipitation, ubiquitin nanobody IP), CRISPR-engineered cell lines","journal":"Molecular & Cellular Proteomics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — quantitative proteomics with two independent enrichment methods and CRISPR controls, identifies specific ubiquitylation site","pmids":["34740826"],"is_preprint":false},{"year":2021,"finding":"Arkadia inactivation in CD4+ T cells impairs iTreg differentiation in vitro and in vivo. Genetic ablation of both SKI and SnoN rescues Arkadia-deficient iTreg cell differentiation, establishing that Arkadia promotes iTreg differentiation by targeting SKI/SnoN for degradation. Arkadia is dispensable for Th17 cell responses.","method":"Conditional KO, double KO rescue/epistasis, flow cytometry, in vivo gut inflammation model","journal":"Journal of Experimental Medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with double KO rescue in vivo, clear pathway placement","pmids":["34473197"],"is_preprint":false},{"year":2020,"finding":"PIAS1 and TIF1γ form a trimeric complex with SnoN and collaborate in an interdependent manner to promote SnoN SUMOylation, leading to suppression of EMT in mammary epithelial organoids. Loss of PIAS1 and TIF1γ shows cooperative requirement for EMT suppression.","method":"Co-immunoprecipitation, in vivo SUMOylation assay, loss-of-function in 3D organoids","journal":"Cell Death and Differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — trimeric complex Co-IP, functional SUMOylation assay, 3D organoid phenotype","pmids":["32770107"],"is_preprint":false},{"year":2023,"finding":"Sumoylation promotes the interaction of SnoN with HDAC1 and p300. HDAC1 suppresses, whereas p300 promotes, TGF-β-induced EMT-associated changes in 3D mammary organoids. Sumoylated SnoN modulates EMT via regulation of histone acetylation.","method":"Co-immunoprecipitation, gain/loss-of-function, 3D mammary organoid assay, histone acetylation analysis","journal":"Cell Death & Disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, functional organoid assay, single lab","pmids":["37414747"],"is_preprint":false},{"year":2011,"finding":"GnRH pulse frequency differentially regulates SKIL (SnoN) expression in gonadotrope cells, where SnoN functions as a corepressor of the FSHβ promoter. Overexpression of Smad-binding or phosphorylation-defective SKIL mutants fails to repress FSHβ promoter activity; SKIL knockdown increases FSHβ promoter activity. ChIP shows FOS and SKIL occupy the FSHβ promoter cyclically after GnRH stimulation.","method":"ChIP, transfection reporter assay, siRNA knockdown, dominant-negative mutant analysis","journal":"Molecular Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus functional reporter and knockdown, single lab","pmids":["21659477"],"is_preprint":false},{"year":2006,"finding":"SnoN binds the smad7 gene promoter at basal conditions and represses it. After short TGF-β treatment, SnoN is downregulated and leaves the promoter; after prolonged TGF-β treatment, upregulated SnoN returns to the smad7 promoter, functioning as a negative feedback control.","method":"Chromatin immunoprecipitation, transcriptional reporter assay","journal":"Biochemical and Biophysical Research Communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct promoter binding with temporal dynamics, single lab","pmids":["16442497"],"is_preprint":false},{"year":1994,"finding":"The C-terminal third of c-Ski mediates stable homodimerization with itself and heterodimerization with SnoN. Two structural motifs constitute the dimerization domain: a domain of five tandem 25-amino-acid repeats required for dimerization, and a predicted leucine zipper that enhances dimerization. c-Ski forms heterodimers with SnoN that are detectable by cross-linking of native protein.","method":"In vitro translated protein cross-linking, bacterial fusion protein pulldown, deletion analysis","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro interaction mapping with deletion analysis, single lab, consistent with later studies","pmids":["7929440"],"is_preprint":false},{"year":1998,"finding":"SnoN binds a specific DNA sequence (GTCTAGAC) and represses transcription through a tripartite repression domain. One subdomain of SnoN interacts with TAF(II)110 as part of a quenching mechanism of transcriptional repression. Two of the three repression subdomains are required for both DNA binding and cellular transformation.","method":"Transcriptional reporter assay, Gal4 fusion assay, deletion mutagenesis, transformation assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic domain analysis with functional readouts, single lab","pmids":["9824161"],"is_preprint":false},{"year":1999,"finding":"c-Ski and SnoN preferentially form heterodimers over homodimers when co-expressed. Tethered Ski:Sno heterodimers lacking TR/LZ domains are more active than monomeric counterparts or tethered homodimers in transcriptional repression and cellular transformation.","method":"In vitro transcription/translation co-expression, DNA binding assay, transformation assay, tethered dimer constructs","journal":"Nucleic Acids Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo dimerization assays with functional consequence, single lab","pmids":["9927733"],"is_preprint":false},{"year":2002,"finding":"c-Ski and SnoN bind to the 'SE' sequence in the C-terminal MH2 domain of Smad3, with 'QPSMT' sequence nearby supporting the interaction. Similar sequences exist in Smad2 but not Smad1, explaining preferential binding. Smurf2 is located close to SnoN via binding to the linker region of Smad2, enabling ubiquitin-dependent degradation of SnoN.","method":"Mutagenesis, binding assays, structural analysis of Smad3 MH2 domain","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic mutagenesis defining binding interface, single lab","pmids":["12426322"],"is_preprint":false},{"year":2024,"finding":"NSUN2 RNA methyltransferase induces m5C modification of SKIL mRNA, stabilizing it via Y-box binding protein 1 (YBX1)-mediated recognition. Elevated SKIL levels in turn increase TAZ transcriptional coactivator activation, promoting colorectal cancer progression.","method":"m5C-methylated RNA immunoprecipitation, RNA stability assay, NSUN2 knockout mouse, siRNA knockdown, Co-immunoprecipitation","journal":"Clinical and Translational Medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct m5C modification demonstrated biochemically with functional mRNA stability readout, single lab","pmids":["38468490"],"is_preprint":false},{"year":2013,"finding":"SKIL (SnoN) overexpression induces cell invasion in immortalized human mammary epithelial cells, and SKIL induces invasion through upregulation of SLUG (SNAI2) expression. Co-expression of TLOC1 and SKIL induces subcutaneous tumor growth in vivo.","method":"Gain-of-function genetic screen, invasion assay, gene expression analysis, xenograft tumor assay","journal":"Cancer Discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional genetic screen with defined molecular mechanism (SLUG upregulation), in vivo xenograft","pmids":["23764425"],"is_preprint":false}],"current_model":"SKIL/SnoN is a nuclear and cytoplasmic transcriptional coregulator that negatively modulates TGF-β/Smad signaling by directly binding Smad2, Smad3, and Smad4 to repress target gene transcription via recruitment of N-CoR, HDACs, and disruption of Smad complexes; it is subject to rapid, signal-induced ubiquitin-proteasomal degradation mediated by at least three distinct E3 ubiquitin ligase complexes (Smad3-APC/Cdh1, Smad2-Smurf2, and Arkadia/RNF111), with Arkadia ubiquitylating SnoN specifically at K343 of its SAND domain; SnoN is also post-translationally modified by SUMOylation (at K50/K383, via PIAS1/TIF1γ) which promotes promoter-specific transcriptional repression and suppression of EMT through recruitment of HDAC1/p300; beyond TGF-β, SnoN intersects the Hippo pathway by inhibiting Lats2-mediated TAZ phosphorylation, promotes ALK1-Smad1/5 angiogenic signaling, interacts with PML to stabilize p53 and induce senescence, interacts with ERα to enhance estrogen-dependent transcription, and in neurons drives axonal morphogenesis through a Smad2-SnoN-Ccd1-JNK pathway and granule neuron precursor proliferation through interactions with N-myc and Pax6."},"narrative":{"mechanistic_narrative":"SKIL (SnoN) is a transcriptional coregulator that functions as a central negative-feedback node of the TGF-β/Smad pathway, directly binding Smad2, Smad3, and Smad4 to repress TGF-β-responsive genes in the absence of ligand through recruitment of the N-CoR corepressor and histone deacetylases [PMID:10531062, PMID:10535941, PMID:12764135]. Repression requires intact Smad-binding regions, and this same activity underlies its oncogenic transforming potential, linking Smad antagonism directly to transformation [PMID:12764135]. Structural work shows the SnoN SAND domain engages the SMAD4 MH2 domain in a manner compatible with simultaneous coordination of R-Smads, forming a stable Smad3–Smad4–SnoN complex [PMID:28397834]. SnoN itself is subject to tightly controlled signal-induced destruction: TGF-β triggers its rapid ubiquitin-proteasomal degradation through at least three distinct E3 ligase routes — a Smad3-recruited APC/CDH1 complex acting on a destruction box, a Smad2–Smurf2 complex, and Arkadia/RNF111, which ubiquitylates SnoN specifically at K343 in the SAND domain only when complexed with phosphorylated Smad2/3 [PMID:11691834, PMID:11741538, PMID:11389444, PMID:17591695, PMID:17510063, PMID:34740826]. This degradation, augmented by TAK1-mediated phosphorylation, transiently relieves repression before SnoN re-expression re-establishes feedback control [PMID:11691834, PMID:11741538, PMID:17591695, PMID:17510063]. SnoN is also SUMOylated at K50/K383 via PIAS1/TIF1γ, a modification that promotes promoter-specific repression and suppresses EMT through HDAC1/p300 recruitment without altering protein stability [PMID:16966324, PMID:17202138, PMID:32770107, PMID:37414747]. Beyond canonical TGF-β control, SnoN integrates additional signaling axes: it inhibits Lats2-mediated TAZ phosphorylation to stabilize TAZ in the Hippo pathway [PMID:27237790], binds ALK1 to promote Smad1/5 angiogenic signaling [PMID:24019535], and engages PML to stabilize p53 and induce senescence as a Smad-independent tumor-suppressive program [PMID:19745809]. In vivo it controls cerebellar granule neuron precursor proliferation and axonal morphogenesis via a Smad2–SnoN–Ccd1–JNK pathway and interactions with N-myc and Pax6 [PMID:16675394, PMID:18287512, PMID:19339625, PMID:30425119], and governs developmental and tissue-specific fates including endoderm specification, mammary alveologenesis through Stat5, and adipocyte differentiation [PMID:23154981, PMID:22833129, PMID:30030373].","teleology":[{"year":1999,"claim":"Established SnoN as a direct negative regulator of TGF-β signaling, answering how Smad transcriptional output is held off in the basal state and reset after stimulation.","evidence":"Co-IP, reporter assays, and proteasome inhibition showing SnoN-Smad2/3/4 binding, N-CoR recruitment, and TGF-β-induced degradation with delayed re-expression","pmids":["10531062","10535941"],"confidence":"High","gaps":["Mechanism coupling Smad nuclear accumulation to SnoN turnover not yet defined","Promoter-level chromatin events not resolved"]},{"year":2001,"claim":"Defined the E3 ligase machinery for signal-induced SnoN destruction, explaining how TGF-β rapidly clears the repressor to permit gene activation.","evidence":"In vitro ubiquitination reconstitution, Co-IP, and mutagenesis identifying Smad3-recruited APC/CDH1 (D-box dependent) and Smad2–Smurf2 complexes","pmids":["11389444","11691834","11741538"],"confidence":"High","gaps":["Relative contribution of each ligase in different cell types unresolved","Did not yet identify all ubiquitin acceptor lysines"]},{"year":2002,"claim":"Mapped the molecular interface for Smad recognition, explaining preferential binding to Smad2/3 over Smad1 and positioning of the degradation machinery.","evidence":"Mutagenesis and binding assays defining the SE/QPSMT sequences in the Smad3 MH2 domain and Smurf2 docking on the Smad2 linker","pmids":["12426322"],"confidence":"Medium","gaps":["Structural detail of the interface not yet available at this stage","Single lab"]},{"year":2003,"claim":"Linked SnoN's Smad-repression function causally to its transforming activity, distinguishing the two binding regions required for antagonism.","evidence":"Systematic mutagenesis with reporter, cell-cycle, and transformation assays showing both Smad-binding regions are needed for repression and transformation","pmids":["12764135"],"confidence":"High","gaps":["Downstream transforming target genes not defined here","Single lab"]},{"year":2005,"claim":"Revealed that SnoN can act in the cytoplasm by Smad sequestration, distinguishing nuclear repression from cytoplasmic antagonism and tying localization to cell state.","evidence":"Subcellular fractionation, immunofluorescence, and functional TGF-β assays across cell types","pmids":["16109768"],"confidence":"High","gaps":["Signals controlling nuclear-cytoplasmic shuttling not defined","Determinants of cytoplasmic degradation resistance unclear"]},{"year":2006,"claim":"Identified Arkadia/RNF111 and uncovered SnoN's distinct neuronal role, broadening both its degradation control and its biological functions.","evidence":"siRNA screen, Co-IP, ubiquitination assays for Arkadia; reciprocal Co-IP, RNAi, and in vivo cerebellar electroporation for axonal growth; ChIP for smad7 promoter feedback","pmids":["17591695","17510063","16675394","16442497"],"confidence":"High","gaps":["How Arkadia substrate selectivity is achieved not yet resolved","Neuronal transcriptional targets not yet identified"]},{"year":2006,"claim":"Established SUMOylation as a regulatory layer controlling promoter-specific repression independent of stability.","evidence":"In vivo SUMOylation assays, K50R/K383R mutagenesis, Ubc9/PIAS1 dependence, and myogenin/muscle gene readouts","pmids":["16966324","17202138"],"confidence":"High","gaps":["Mechanism by which SUMO alters promoter selectivity unresolved","Genome-wide SUMO-dependent target set undefined"]},{"year":2008,"claim":"Ordered the neuronal pathway, placing Smad2 upstream of SnoN in Cdh1-APC-controlled axonal morphogenesis.","evidence":"Endogenous Co-IP, RNAi, and genetic epistasis with axon-length measurement","pmids":["18287512"],"confidence":"High","gaps":["Downstream effectors not yet identified at this step"]},{"year":2009,"claim":"Defined effector arms of SnoN function: a Ccd1-JNK axon-growth program and a Smad-independent PML/p53 senescence and tumor-suppressor program.","evidence":"Co-IP, gene profiling, in vivo electroporation for p300/Ccd1; Co-IP, PML body IF, p53 stability, and in vivo carcinogenesis for senescence","pmids":["19339625","19745809"],"confidence":"High","gaps":["Switch between oncogenic and tumor-suppressive outputs not mechanistically defined","Threshold of SnoN level dictating senescence unclear"]},{"year":2010,"claim":"Provided the first structural view of a SnoN interaction domain, revealing conformational flexibility consistent with multipartner recognition.","evidence":"X-ray crystallography of the Dachshund homology domain","pmids":["20957027"],"confidence":"Medium","gaps":["Crystal structure lacks biochemical/mutagenesis validation of the groove","Specific partners engaging the groove not tested"]},{"year":2012,"claim":"Demonstrated direct promoter occupancy and a self-regulating feedback loop, and expanded SnoN's targets to developmental and tissue-specific programs.","evidence":"ChIP/sequential ChIP on SKIL and developmental promoters, reporter assays, gain/loss of function in hESCs, KO mouse rescue with Stat5, and BMP cross-inhibition assays","pmids":["22674574","23154981","22833129","20457602","22767605"],"confidence":"High","gaps":["Genome-wide direct binding map incomplete","Coregulator switching at distinct promoters not fully defined"]},{"year":2011,"claim":"Extended SnoN's corepressor function to ERα-enhanced and GnRH-regulated transcription, showing context-dependent coactivator and corepressor roles.","evidence":"Co-IP, LxxLL mutagenesis, ChIP and reporter assays for ERα; ChIP, reporter and knockdown for FSHβ promoter","pmids":["22227247","21659477"],"confidence":"Medium","gaps":["Mechanistic basis for coactivator versus corepressor switching unresolved","Single lab for each context"]},{"year":2013,"claim":"Defined oncogenic outputs of SnoN amplification, linking it to invasion via SLUG and to tumor growth.","evidence":"Gain-of-function screen, invasion assays, expression analysis, and xenograft tumor assay","pmids":["23764425"],"confidence":"Medium","gaps":["Direct versus indirect regulation of SLUG not resolved","Single lab"]},{"year":2016,"claim":"Connected SnoN to the Hippo pathway, showing it stabilizes TAZ by blocking Lats2 and is reciprocally regulated by Lats2/Scribble.","evidence":"Reciprocal Co-IP, kinase assays, and knockdown/overexpression with TAZ phosphorylation readout","pmids":["27237790"],"confidence":"High","gaps":["Structural basis of Lats2-TAZ disruption undefined","Integration with TGF-β SnoN pool unclear"]},{"year":2017,"claim":"Provided structural and biochemical definition of the SnoN-SMAD4 complex, distinguishing SnoN's stable-complex mode from Ski's heteromer-disrupting mode.","evidence":"X-ray crystallography of the SAND domain–SMAD4 MH2 complex with co-purification and stability assays","pmids":["28397834"],"confidence":"High","gaps":["Structure of full Smad3-Smad4-SnoN assembly not determined","Single lab"]},{"year":2018,"claim":"Established pathway-selective in vivo functions, separating activin-A/Smad2 from TGF-β/Smad3 outputs in adipogenesis and defining granule neuron precursor proliferation control.","evidence":"Conditional KO and Smad-binding mutant mice with metabolic phenotype; conditional KO with RNA-Seq and Co-IP identifying N-myc/Pax6","pmids":["30030373","30425119"],"confidence":"High","gaps":["Basis for Smad2 versus Smad3 selectivity not mechanistically resolved","Direct N-myc/Pax6 target genes undefined"]},{"year":2020,"claim":"Defined the SUMO E3 machinery and its consequence, showing PIAS1/TIF1γ cooperate to SUMOylate SnoN and suppress EMT.","evidence":"Co-IP, in vivo SUMOylation assays, and loss-of-function in 3D organoids","pmids":["32770107"],"confidence":"High","gaps":["Interdependence mechanism of PIAS1/TIF1γ not fully resolved"]},{"year":2021,"claim":"Resolved Arkadia's substrate specificity at proteome scale and demonstrated its physiological role in iTreg differentiation through SKI/SnoN degradation.","evidence":"Quantitative ubiquitylome MS with CRISPR controls identifying K343; conditional and double-KO epistasis in T cells with in vivo gut inflammation model","pmids":["34740826","34473197"],"confidence":"High","gaps":["How RNF111 restricts itself to SKI/SnoN not structurally defined","Role of K343 ubiquitylation in non-immune contexts not tested"]},{"year":2023,"claim":"Showed SUMOylation directs SnoN's coregulator partner choice between HDAC1 and p300 to tune EMT-associated histone acetylation.","evidence":"Co-IP, gain/loss-of-function, and histone acetylation analysis in 3D mammary organoids","pmids":["37414747"],"confidence":"Medium","gaps":["Promoter-level acetylation changes not mapped genome-wide","Single lab"]},{"year":2024,"claim":"Identified upstream RNA-level control of SKIL via m5C methylation, linking transcript stabilization to TAZ activation in cancer.","evidence":"m5C-meRIP, RNA stability assays, NSUN2 KO mouse, and Co-IP","pmids":["38468490"],"confidence":"Medium","gaps":["Generality across tissues of m5C control unknown","Single lab"]},{"year":null,"claim":"How SnoN switches between tumor-suppressive (PML/p53 senescence, Smad repression) and oncogenic (TAZ stabilization, SLUG-driven invasion) outputs in a given cellular context remains undefined.","evidence":"","pmids":[],"confidence":"High","gaps":["No unifying model linking SnoN level, modification state, and context to functional output","Genome-wide direct binding and coregulator-switching map incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,5,17,18,34]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[34,35]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,21,22,19]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2,9,21]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[37]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1,6,16]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[21]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[14,18]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,9,21,22]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,17,18,34]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[2,3,9,27]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[18,19,25,26]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[28]}],"complexes":["Smad3-Smad4-SnoN repressor complex","Smad3-APC/CDH1 ubiquitin ligase complex","Smad2-Smurf2 ubiquitin ligase complex","PIAS1-TIF1γ-SnoN SUMOylation complex"],"partners":["SMAD2","SMAD3","SMAD4","RNF111","SMURF2","PIAS1","TAZ","ALK1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P12757","full_name":"Ski-like protein","aliases":["Ski-related oncogene","Ski-related protein"],"length_aa":684,"mass_kda":77.0,"function":"May have regulatory role in cell division or differentiation in response to extracellular signals","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P12757/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SKIL","classification":"Not Classified","n_dependent_lines":10,"n_total_lines":1208,"dependency_fraction":0.008278145695364239},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"NANS","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/SKIL","total_profiled":1310},"omim":[{"mim_id":"165340","title":"SKI-LIKE; SKIL","url":"https://www.omim.org/entry/165340"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SKIL"},"hgnc":{"alias_symbol":["SNO","SnoN","SnoA"],"prev_symbol":[]},"alphafold":{"accession":"P12757","domains":[{"cath_id":"3.10.260.20","chopping":"145-236","consensus_level":"high","plddt":91.9313,"start":145,"end":236},{"cath_id":"3.10.390.10","chopping":"260-355","consensus_level":"high","plddt":90.0315,"start":260,"end":355}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P12757","model_url":"https://alphafold.ebi.ac.uk/files/AF-P12757-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P12757-F1-predicted_aligned_error_v6.png","plddt_mean":65.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SKIL","jax_strain_url":"https://www.jax.org/strain/search?query=SKIL"},"sequence":{"accession":"P12757","fasta_url":"https://rest.uniprot.org/uniprotkb/P12757.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P12757/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P12757"}},"corpus_meta":[{"pmid":"10531062","id":"PMC_10531062","title":"Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein.","date":"1999","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10531062","citation_count":433,"is_preprint":false},{"pmid":"11389444","id":"PMC_11389444","title":"TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation.","date":"2001","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11389444","citation_count":269,"is_preprint":false},{"pmid":"19114989","id":"PMC_19114989","title":"Ski and SnoN, potent negative regulators of TGF-beta signaling.","date":"2009","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/19114989","citation_count":227,"is_preprint":false},{"pmid":"10535941","id":"PMC_10535941","title":"SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10535941","citation_count":221,"is_preprint":false},{"pmid":"11691834","id":"PMC_11691834","title":"Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN.","date":"2001","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/11691834","citation_count":186,"is_preprint":false},{"pmid":"11741538","id":"PMC_11741538","title":"The anaphase-promoting complex mediates TGF-beta signaling by targeting SnoN for destruction.","date":"2001","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/11741538","citation_count":153,"is_preprint":false},{"pmid":"17591695","id":"PMC_17591695","title":"Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17591695","citation_count":148,"is_preprint":false},{"pmid":"17510063","id":"PMC_17510063","title":"Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17510063","citation_count":144,"is_preprint":false},{"pmid":"16675394","id":"PMC_16675394","title":"Cell-intrinsic regulation of axonal morphogenesis by the Cdh1-APC target SnoN.","date":"2006","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/16675394","citation_count":143,"is_preprint":false},{"pmid":"20508647","id":"PMC_20508647","title":"Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells.","date":"2010","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/20508647","citation_count":117,"is_preprint":false},{"pmid":"29892481","id":"PMC_29892481","title":"Transcriptional cofactors Ski and SnoN are major regulators of the TGF-β/Smad signaling pathway in health and disease.","date":"2018","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29892481","citation_count":102,"is_preprint":false},{"pmid":"17074815","id":"PMC_17074815","title":"Dual role of SnoN in mammalian tumorigenesis.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17074815","citation_count":88,"is_preprint":false},{"pmid":"12764135","id":"PMC_12764135","title":"The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12764135","citation_count":88,"is_preprint":false},{"pmid":"8426750","id":"PMC_8426750","title":"Sequence and biological activity of chicken snoN cDNA clones.","date":"1993","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8426750","citation_count":83,"is_preprint":false},{"pmid":"18287512","id":"PMC_18287512","title":"TGFbeta-Smad2 signaling regulates the Cdh1-APC/SnoN pathway of axonal morphogenesis.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18287512","citation_count":80,"is_preprint":false},{"pmid":"12023281","id":"PMC_12023281","title":"Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12023281","citation_count":76,"is_preprint":false},{"pmid":"23764425","id":"PMC_23764425","title":"Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers.","date":"2013","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/23764425","citation_count":72,"is_preprint":false},{"pmid":"14638915","id":"PMC_14638915","title":"Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling.","date":"2003","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/14638915","citation_count":72,"is_preprint":false},{"pmid":"16109768","id":"PMC_16109768","title":"Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16109768","citation_count":66,"is_preprint":false},{"pmid":"22958403","id":"PMC_22958403","title":"Transforming growth factor β1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy?","date":"2012","source":"BMC medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22958403","citation_count":64,"is_preprint":false},{"pmid":"16625151","id":"PMC_16625151","title":"Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury.","date":"2006","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/16625151","citation_count":63,"is_preprint":false},{"pmid":"38468490","id":"PMC_38468490","title":"NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization.","date":"2024","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38468490","citation_count":62,"is_preprint":false},{"pmid":"15677458","id":"PMC_15677458","title":"SnoN is a cell type-specific mediator of transforming growth factor-beta responses.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15677458","citation_count":60,"is_preprint":false},{"pmid":"16959829","id":"PMC_16959829","title":"Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation.","date":"2006","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/16959829","citation_count":59,"is_preprint":false},{"pmid":"19339625","id":"PMC_19339625","title":"A SnoN-Ccd1 pathway promotes axonal morphogenesis in the mammalian brain.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19339625","citation_count":52,"is_preprint":false},{"pmid":"20093492","id":"PMC_20093492","title":"Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression.","date":"2010","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20093492","citation_count":48,"is_preprint":false},{"pmid":"22674574","id":"PMC_22674574","title":"Transforming growth factor-β/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNON-SMAD4.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22674574","citation_count":46,"is_preprint":false},{"pmid":"22767605","id":"PMC_22767605","title":"SnoN suppresses maturation of chondrocytes by mediating signal cross-talk between transforming growth factor-β and bone morphogenetic protein pathways.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22767605","citation_count":44,"is_preprint":false},{"pmid":"16966324","id":"PMC_16966324","title":"Sumoylated SnoN represses transcription in a promoter-specific manner.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16966324","citation_count":43,"is_preprint":false},{"pmid":"12426322","id":"PMC_12426322","title":"Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12426322","citation_count":43,"is_preprint":false},{"pmid":"7929440","id":"PMC_7929440","title":"A carboxyl-terminal region of the ski oncoprotein mediates homodimerization as well as heterodimerization with the related protein SnoN.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7929440","citation_count":43,"is_preprint":false},{"pmid":"27010330","id":"PMC_27010330","title":"Oxymatrine Inhibits Renal Tubular EMT Induced by High Glucose via Upregulation of SnoN and Inhibition of TGF-β1/Smad Signaling Pathway.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27010330","citation_count":42,"is_preprint":false},{"pmid":"33268765","id":"PMC_33268765","title":"SKIL facilitates tumorigenesis and immune escape of NSCLC via upregulating TAZ/autophagy axis.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33268765","citation_count":41,"is_preprint":false},{"pmid":"16314499","id":"PMC_16314499","title":"Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16314499","citation_count":41,"is_preprint":false},{"pmid":"21211030","id":"PMC_21211030","title":"Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression.","date":"2011","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21211030","citation_count":40,"is_preprint":false},{"pmid":"15930298","id":"PMC_15930298","title":"Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/15930298","citation_count":40,"is_preprint":false},{"pmid":"31879190","id":"PMC_31879190","title":"AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis by Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI Axis.","date":"2019","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31879190","citation_count":39,"is_preprint":false},{"pmid":"34473197","id":"PMC_34473197","title":"Arkadia-SKI/SnoN signaling differentially regulates TGF-β-induced iTreg and Th17 cell differentiation.","date":"2021","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34473197","citation_count":36,"is_preprint":false},{"pmid":"20822955","id":"PMC_20822955","title":"SnoN in mammalian development, function and diseases.","date":"2010","source":"Current opinion in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20822955","citation_count":35,"is_preprint":false},{"pmid":"32319565","id":"PMC_32319565","title":"miR‑574‑5p attenuates proliferation, migration and EMT in triple‑negative breast cancer cells by targeting BCL11A and SOX2 to inhibit the SKIL/TAZ/CTGF axis.","date":"2020","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32319565","citation_count":35,"is_preprint":false},{"pmid":"17276978","id":"PMC_17276978","title":"TAK1 MAPK kinase kinase mediates transforming growth factor-beta signaling by targeting SnoN oncoprotein for degradation.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17276978","citation_count":35,"is_preprint":false},{"pmid":"9927733","id":"PMC_9927733","title":"Heterodimers of the SnoN and Ski oncoproteins form preferentially over homodimers and are more potent transforming agents.","date":"1999","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9927733","citation_count":34,"is_preprint":false},{"pmid":"28707079","id":"PMC_28707079","title":"Down-regulation of miR-23a inhibits high glucose-induced EMT and renal fibrogenesis by up-regulation of SnoN.","date":"2017","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/28707079","citation_count":34,"is_preprint":false},{"pmid":"25380815","id":"PMC_25380815","title":"SnoN as a novel negative regulator of TGF-β/Smad signaling: a target for tailoring organ fibrosis.","date":"2014","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25380815","citation_count":33,"is_preprint":false},{"pmid":"21659477","id":"PMC_21659477","title":"Gonadotropin-releasing hormone pulse sensitivity of follicle-stimulating hormone-beta gene is mediated by differential expression of positive regulatory activator protein 1 factors and corepressors SKIL and TGIF1.","date":"2011","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/21659477","citation_count":32,"is_preprint":false},{"pmid":"19745809","id":"PMC_19745809","title":"SnoN functions as a tumour suppressor by inducing premature senescence.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19745809","citation_count":31,"is_preprint":false},{"pmid":"27237790","id":"PMC_27237790","title":"SnoN Antagonizes the Hippo Kinase Complex to Promote TAZ Signaling during Breast Carcinogenesis.","date":"2016","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/27237790","citation_count":30,"is_preprint":false},{"pmid":"20457602","id":"PMC_20457602","title":"The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20457602","citation_count":30,"is_preprint":false},{"pmid":"18537639","id":"PMC_18537639","title":"SnoN in TGF-beta signaling and cancer biology.","date":"2008","source":"Current molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18537639","citation_count":29,"is_preprint":false},{"pmid":"35314669","id":"PMC_35314669","title":"BMP-7 ameliorates partial epithelial-mesenchymal transition by restoring SnoN protein level via Smad1/5 pathway in diabetic kidney disease.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35314669","citation_count":29,"is_preprint":false},{"pmid":"25029526","id":"PMC_25029526","title":"Potential therapeutic targets for oral cancer: ADM, TP53, EGFR, LYN, CTLA4, SKIL, CTGF, CD70.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25029526","citation_count":29,"is_preprint":false},{"pmid":"31836508","id":"PMC_31836508","title":"miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN.","date":"2019","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31836508","citation_count":28,"is_preprint":false},{"pmid":"25003128","id":"PMC_25003128","title":"The proteasome inhibitor, MG132, attenuates diabetic nephropathy by inhibiting SnoN degradation in vivo and in vitro.","date":"2014","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/25003128","citation_count":28,"is_preprint":false},{"pmid":"17625116","id":"PMC_17625116","title":"Molecular basis for the cell type specific induction of SnoN expression by hepatocyte growth factor.","date":"2007","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/17625116","citation_count":27,"is_preprint":false},{"pmid":"19096149","id":"PMC_19096149","title":"TGF-beta repressors SnoN and Ski are implicated in human colorectal carcinogenesis.","date":"2009","source":"Cellular oncology : the official journal of the International Society for Cellular Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19096149","citation_count":27,"is_preprint":false},{"pmid":"23832742","id":"PMC_23832742","title":"Cooperative involvement of NFAT and SnoN mediates transforming growth factor-β (TGF-β) induced EMT in metastatic breast cancer (MDA-MB 231) cells.","date":"2013","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/23832742","citation_count":27,"is_preprint":false},{"pmid":"23154981","id":"PMC_23154981","title":"The SMAD2/3 corepressor SNON maintains pluripotency through selective repression of mesendodermal genes in human ES cells.","date":"2012","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/23154981","citation_count":26,"is_preprint":false},{"pmid":"20460516","id":"PMC_20460516","title":"Transforming growth factor-beta regulator SnoN modulates mammary gland branching morphogenesis, postlactational involution, and mammary tumorigenesis.","date":"2010","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20460516","citation_count":26,"is_preprint":false},{"pmid":"31471872","id":"PMC_31471872","title":"SNHG14 promotes the tumorigenesis and metastasis of colorectal cancer through miR-32-5p/SKIL axis.","date":"2019","source":"In vitro cellular & developmental biology. Animal","url":"https://pubmed.ncbi.nlm.nih.gov/31471872","citation_count":25,"is_preprint":false},{"pmid":"18261624","id":"PMC_18261624","title":"Ski/SnoN expression in the sequence metaplasia-dysplasia-adenocarcinoma of Barrett's esophagus.","date":"2008","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18261624","citation_count":25,"is_preprint":false},{"pmid":"22833129","id":"PMC_22833129","title":"SnoN regulates mammary gland alveologenesis and onset of lactation by promoting prolactin/Stat5 signaling.","date":"2012","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22833129","citation_count":24,"is_preprint":false},{"pmid":"23590892","id":"PMC_23590892","title":"Docosahexaenoic acid (DHA) ameliorates paraquat-induced pulmonary fibrosis in rats possibly through up-regulation of Smad 7 and SnoN.","date":"2013","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/23590892","citation_count":24,"is_preprint":false},{"pmid":"23154181","id":"PMC_23154181","title":"SnoN/SKIL modulates proliferation through control of hsa-miR-720 transcription in esophageal cancer cells.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23154181","citation_count":23,"is_preprint":false},{"pmid":"25749039","id":"PMC_25749039","title":"Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25749039","citation_count":22,"is_preprint":false},{"pmid":"23621864","id":"PMC_23621864","title":"Phospholipid Scramblase 1, an interferon-regulated gene located at 3q23, is regulated by SnoN/SkiL in ovarian cancer cells.","date":"2013","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23621864","citation_count":22,"is_preprint":false},{"pmid":"19383336","id":"PMC_19383336","title":"Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis.","date":"2008","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19383336","citation_count":22,"is_preprint":false},{"pmid":"9824161","id":"PMC_9824161","title":"A domain necessary for the transforming activity of SnoN is required for specific DNA binding, transcriptional repression and interaction with TAF(II)110.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9824161","citation_count":22,"is_preprint":false},{"pmid":"22710173","id":"PMC_22710173","title":"SnoN signaling in proliferating cells and postmitotic neurons.","date":"2012","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/22710173","citation_count":20,"is_preprint":false},{"pmid":"28115165","id":"PMC_28115165","title":"Repression of Smad3 by Stat3 and c-Ski/SnoN induces gefitinib resistance in lung adenocarcinoma.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28115165","citation_count":20,"is_preprint":false},{"pmid":"26743567","id":"PMC_26743567","title":"The downregulation of SnoN expression in human renal proximal tubule epithelial cells under high-glucose conditions is mediated by an increase in Smurf2 expression through TGF-β1 signaling.","date":"2015","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26743567","citation_count":20,"is_preprint":false},{"pmid":"29211876","id":"PMC_29211876","title":"Interplay between FMRP and lncRNA TUG1 regulates axonal development through mediating SnoN-Ccd1 pathway.","date":"2018","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29211876","citation_count":20,"is_preprint":false},{"pmid":"31917288","id":"PMC_31917288","title":"Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN.","date":"2020","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31917288","citation_count":20,"is_preprint":false},{"pmid":"18782659","id":"PMC_18782659","title":"Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-beta resistance, in primary cutaneous melanoma.","date":"2008","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/18782659","citation_count":20,"is_preprint":false},{"pmid":"17202138","id":"PMC_17202138","title":"Transforming growth factor-beta-independent regulation of myogenesis by SnoN sumoylation.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17202138","citation_count":19,"is_preprint":false},{"pmid":"24019535","id":"PMC_24019535","title":"SnoN facilitates ALK1-Smad1/5 signaling during embryonic angiogenesis.","date":"2013","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24019535","citation_count":18,"is_preprint":false},{"pmid":"23178716","id":"PMC_23178716","title":"SnoN/SkiL expression is modulated via arsenic trioxide-induced activation of the PI3K/AKT pathway in ovarian cancer cells.","date":"2012","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/23178716","citation_count":17,"is_preprint":false},{"pmid":"28350874","id":"PMC_28350874","title":"SnoN upregulation ameliorates renal fibrosis in diabetic nephropathy.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28350874","citation_count":17,"is_preprint":false},{"pmid":"19920850","id":"PMC_19920850","title":"Oncogene and tumour suppressor: the two faces of SnoN.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19920850","citation_count":17,"is_preprint":false},{"pmid":"22813962","id":"PMC_22813962","title":"SnoN as a key regulator of the high glucose-induced epithelial-mesenchymal transition in cells of the proximal tubule.","date":"2012","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/22813962","citation_count":17,"is_preprint":false},{"pmid":"16442497","id":"PMC_16442497","title":"SnoN co-repressor binds and represses smad7 gene promoter.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16442497","citation_count":16,"is_preprint":false},{"pmid":"28397834","id":"PMC_28397834","title":"SnoN Stabilizes the SMAD3/SMAD4 Protein Complex.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28397834","citation_count":15,"is_preprint":false},{"pmid":"27430247","id":"PMC_27430247","title":"SnoN suppresses TGF-β-induced epithelial-mesenchymal transition and invasion of bladder cancer in a TIF1γ-dependent manner.","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/27430247","citation_count":15,"is_preprint":false},{"pmid":"34740826","id":"PMC_34740826","title":"Quantitative Ubiquitylome Analysis Reveals the Specificity of RNF111/Arkadia E3 Ubiquitin Ligase for its Degradative Substrates SKI and SKIL/SnoN in TGF-β Signaling Pathway.","date":"2021","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/34740826","citation_count":14,"is_preprint":false},{"pmid":"20699661","id":"PMC_20699661","title":"SnoN/SkiL, a TGFβ signaling mediator: a participant in autophagy induced by arsenic trioxide.","date":"2010","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/20699661","citation_count":14,"is_preprint":false},{"pmid":"28447757","id":"PMC_28447757","title":"Molecular mechanism of smurf2 in regulating the expression of SnoN in diabetic nephropathy.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28447757","citation_count":14,"is_preprint":false},{"pmid":"32770107","id":"PMC_32770107","title":"PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.","date":"2020","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/32770107","citation_count":13,"is_preprint":false},{"pmid":"22227247","id":"PMC_22227247","title":"SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.","date":"2011","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/22227247","citation_count":13,"is_preprint":false},{"pmid":"28765970","id":"PMC_28765970","title":"BMP-7 enhances SnoN mRNA expression in renal tubular epithelial cells under high-glucose conditions.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28765970","citation_count":13,"is_preprint":false},{"pmid":"17289352","id":"PMC_17289352","title":"Drosophila SnoN modulates growth and patterning by antagonizing TGF-beta signalling.","date":"2006","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/17289352","citation_count":13,"is_preprint":false},{"pmid":"8955358","id":"PMC_8955358","title":"A transient increase of snoN transcript by growth arrest upon serum deprivation and cell-to-cell contact.","date":"1996","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8955358","citation_count":13,"is_preprint":false},{"pmid":"22710172","id":"PMC_22710172","title":"SnoN in regulation of embryonic development and tissue morphogenesis.","date":"2012","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/22710172","citation_count":12,"is_preprint":false},{"pmid":"30425119","id":"PMC_30425119","title":"The Transcriptional Regulator SnoN Promotes the Proliferation of Cerebellar Granule Neuron Precursors in the Postnatal Mouse Brain.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30425119","citation_count":12,"is_preprint":false},{"pmid":"17062133","id":"PMC_17062133","title":"SnoN expression is differently regulated in microsatellite unstable compared with microsatellite stable colorectal cancers.","date":"2006","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17062133","citation_count":12,"is_preprint":false},{"pmid":"30030373","id":"PMC_30030373","title":"The regulatory protein SnoN antagonizes activin/Smad2 protein signaling and thereby promotes adipocyte differentiation and obesity in mice.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30030373","citation_count":11,"is_preprint":false},{"pmid":"27122545","id":"PMC_27122545","title":"MAD2B-mediated SnoN downregulation is implicated in fibroblast activation and tubulointerstitial fibrosis.","date":"2016","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27122545","citation_count":11,"is_preprint":false},{"pmid":"26002202","id":"PMC_26002202","title":"Actin-cytoskeleton polymerization differentially controls the stability of Ski and SnoN co-repressors in normal but not in transformed hepatocytes.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/26002202","citation_count":11,"is_preprint":false},{"pmid":"20957027","id":"PMC_20957027","title":"The crystal structure of the Dachshund domain of human SnoN reveals flexibility in the putative protein interaction surface.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20957027","citation_count":11,"is_preprint":false},{"pmid":"37414747","id":"PMC_37414747","title":"Sumoylated SnoN interacts with HDAC1 and p300/CBP to regulate EMT-associated phenotypes in mammary organoids.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37414747","citation_count":10,"is_preprint":false},{"pmid":"19538364","id":"PMC_19538364","title":"The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.","date":"2009","source":"International journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/19538364","citation_count":10,"is_preprint":false},{"pmid":"17469184","id":"PMC_17469184","title":"Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts.","date":"2007","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/17469184","citation_count":10,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49489,"output_tokens":9039,"usd":0.142026,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19211,"output_tokens":6087,"usd":0.124115,"stage2_stop_reason":"end_turn"},"total_usd":0.266141,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"SnoN directly interacts with Smad2 and Smad4, represses their transcriptional activity through recruitment of the transcriptional corepressor N-CoR, and maintains the repressed state of TGF-β-responsive genes in the absence of ligand. Upon TGF-β stimulation, Smad3 nuclear accumulation leads to rapid SnoN degradation, allowing target gene activation; by 2 hours, TGF-β induces SnoN re-expression to terminate Smad-mediated transactivation (negative feedback).\",\n      \"method\": \"Co-immunoprecipitation, transcriptional reporter assays, Western blotting\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP and functional reporter assays, replicated in multiple subsequent studies\",\n      \"pmids\": [\"10531062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Smad3 associates with SnoN in the nucleus; overexpression of SnoN represses Smad3-mediated transcriptional activation. TGF-β stimulation leads to rapid, proteasome-mediated degradation of SnoN.\",\n      \"method\": \"Co-immunoprecipitation, transcriptional reporter assay, proteasome inhibitor treatment\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP plus functional assay plus pharmacological evidence, independently replicated\",\n      \"pmids\": [\"10535941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"TGF-β induces assembly of a Smad2–Smurf2 ubiquitin ligase complex that targets SnoN for ubiquitin-mediated proteasomal degradation. Smad2 interacts with Smurf2 via its PPXY motif and WW domains, and Smad2 mediates the interaction of Smurf2 with SnoN.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, proteasome inhibitor treatment\",\n      \"journal\": \"Nature Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — biochemical reconstitution of the complex, multiple orthogonal methods, replicated by independent labs\",\n      \"pmids\": [\"11389444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Smad3 (and to a lesser extent Smad2) recruits the anaphase-promoting complex (APC) with UbcH5 ubiquitin-conjugating enzymes to SnoN, causing ubiquitination at a destruction box (D box) and proteasomal degradation of SnoN. Mutation of the Smad3-binding site or key lysine residues in SnoN stabilizes it and enhances antagonism of TGF-β signaling.\",\n      \"method\": \"In vitro ubiquitination assay, co-immunoprecipitation, mutagenesis, proteasome inhibitor treatment\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro ubiquitination reconstitution with mutagenesis, replicated by independent lab (PMID 11741538)\",\n      \"pmids\": [\"11691834\", \"11741538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The APC activator CDH1 forms a quaternary complex with SnoN, Smad3, and APC to mediate SnoN destruction in response to TGF-β. The destruction box of SnoN is required for its degradation.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, mutagenesis\",\n      \"journal\": \"Molecular Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — biochemical complex reconstitution and mutagenesis, consistent with independent study (PMID 11691834)\",\n      \"pmids\": [\"11741538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Smad2 and Smad3 bind to distinct regions of SnoN; mutation of both Smad-binding regions (but not individually) impairs SnoN-mediated repression of TGF-β transcription and cell cycle arrest. Mutant SnoN defective in Smad binding fails to induce oncogenic transformation, demonstrating that transforming activity requires Smad repression.\",\n      \"method\": \"Mutagenesis, co-immunoprecipitation, transcriptional reporter assay, transformation assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic mutagenesis with multiple functional readouts in single lab\",\n      \"pmids\": [\"12764135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In normal tissues and non-tumorigenic epithelial cells, SnoN is predominantly cytoplasmic and antagonizes TGF-β signaling by sequestering Smad proteins in the cytoplasm rather than by nuclear transcriptional repression. Cytoplasmic SnoN is resistant to TGF-β-induced degradation. Upon differentiation or cell-cycle arrest, SnoN translocates to the nucleus.\",\n      \"method\": \"Subcellular fractionation, immunofluorescence, functional TGF-β signaling assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — fractionation plus functional assays with multiple cell types, single lab\",\n      \"pmids\": [\"16109768\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Cdh1-APC forms a physical complex with SnoN in neurons and stimulates ubiquitin-dependent proteasomal degradation of SnoN. SnoN promotes axonal growth downstream of Cdh1-APC; SnoN knockdown reduces axonal growth and suppresses Cdh1 RNAi-induced axonal enhancement. SnoN is required for cerebellar granule neuron parallel fiber development in vivo.\",\n      \"method\": \"Co-immunoprecipitation, RNAi knockdown, in vivo cerebellar electroporation, axon length quantification\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, genetic epistasis, in vivo knockdown with defined phenotype, replicated in follow-up studies\",\n      \"pmids\": [\"16675394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SnoN is sumoylated primarily at lysine residues 50 and 383. The SUMO E2 enzyme Ubc9 is critical for this modification and SUMO E3 ligase PIAS1 selectively interacts with and enhances SnoN sumoylation. Sumoylation of SnoN augments its ability to repress gene expression in a promoter-specific manner, particularly suppressing myogenin transcription.\",\n      \"method\": \"In vivo sumoylation assay, mutagenesis (K50R, K383R), co-immunoprecipitation, transcriptional reporter assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — site-directed mutagenesis identifying SUMO acceptor sites, functional assays, replicated by independent lab (PMID 17202138)\",\n      \"pmids\": [\"16966324\", \"17202138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Arkadia (RNF111), an E3 ubiquitin ligase, interacts with SnoN, induces its ubiquitination, and is essential for TGF-β-induced SnoN degradation. SnoN is efficiently degraded only when it forms a complex with both Arkadia and phosphorylated Smad2 or Smad3. Arkadia is required for Smad3/Smad4-dependent transcription but not for Smad1/Smad4 or Smad2/Smad4/FoxH1-dependent responses.\",\n      \"method\": \"siRNA library screen, co-immunoprecipitation, ubiquitination assay, transcriptional reporter assay, dominant-negative mutant\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods, confirmed in independent lab (PMID 17510063)\",\n      \"pmids\": [\"17591695\", \"17510063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TAK1 (MAP3K7) interacts with and phosphorylates SnoN; this phosphorylation destabilizes SnoN. Inactivation of TAK1 prevents TGF-β-induced SnoN degradation and impairs induction of TGF-β-responsive genes.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, TAK1 dominant-negative/knockdown, Western blotting\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinase assay plus functional consequence, single lab\",\n      \"pmids\": [\"17276978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"SnoN sumoylation at lysine 50 is regulated by PIAS1 and PIASx as SUMO E3 ligases. Loss of sumoylation (K50R mutation) potently activates muscle-specific gene expression and enhances myotube formation. Sumoylation does not alter SnoN stability or its ability to repress TGF-β signaling but specifically controls myogenic differentiation.\",\n      \"method\": \"In vivo sumoylation assay, mutagenesis, myotube formation assay, gene expression analysis\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — site-directed mutagenesis with clear functional phenotype, consistent with PMID 16966324\",\n      \"pmids\": [\"17202138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In neurons, TGFβ-regulated Smad2 is phosphorylated and localized in the nucleus where it forms a physical complex with endogenous SnoN. Smad2 knockdown stimulates axonal growth. Epistasis analyses show Smad2 acts upstream of SnoN in the Cdh1-APC pathway controlling axonal morphogenesis.\",\n      \"method\": \"Co-immunoprecipitation of endogenous proteins, RNAi knockdown, genetic epistasis, axon length measurement\",\n      \"journal\": \"Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — endogenous protein Co-IP, multiple knockdown approaches, genetic epistasis establishing pathway order\",\n      \"pmids\": [\"18287512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SnoN interacts with the coactivator p300 in neurons, and p300 is required for SnoN-induced axon growth. SnoN transcriptionally activates the Ccd1 gene; Ccd1 localizes to the actin cytoskeleton at axon terminals, activates JNK, and is required for SnoN-dependent axonal growth in vivo.\",\n      \"method\": \"Co-immunoprecipitation, gene profiling, RNAi knockdown, in vivo cerebellar electroporation\",\n      \"journal\": \"Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, transcriptional target identification, genetic epistasis, in vivo knockdown\",\n      \"pmids\": [\"19339625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"High levels of SnoN induce premature senescence by a Smad-independent mechanism: SnoN interacts with PML protein, is recruited to PML nuclear bodies, and stabilizes p53. SnoN overexpression inhibits oncogenic transformation by Ras and Myc and blocks papilloma development in vivo.\",\n      \"method\": \"Co-immunoprecipitation, PML nuclear body immunofluorescence, p53 stability assay, in vivo carcinogenesis model\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, functional localization to PML bodies, in vivo tumor suppressor phenotype with multiple methods\",\n      \"pmids\": [\"19745809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SnoN acts as a master repressor of ADAM12 gene expression in response to TGF-β1 stimulation. SnoN overexpression reduces TGF-β1-induced ADAM12 induction; SnoN shRNA knockdown enhances it. This repression is Smad2/Smad3-dependent and occurs via derepression of the Adam12 gene.\",\n      \"method\": \"shRNA knockdown, overexpression, mRNA/protein analysis, Smad2/3 dependence assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain and loss of function with defined molecular target, single lab\",\n      \"pmids\": [\"20457602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SnoN interacts with the estrogen-activated form of ERα in the nucleus via conserved LxxLL-like motifs. SnoN overexpression enhances ERα transcriptional activity at ERE-reporter and target genes; SnoN knockdown reduces it. SnoN supports p300 recruitment to the ERα target gene TTF1 promoter.\",\n      \"method\": \"Co-immunoprecipitation, LxxLL mutagenesis, chromatin immunoprecipitation, transcriptional reporter assay\",\n      \"journal\": \"Cellular Signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with mutagenesis and ChIP, single lab\",\n      \"pmids\": [\"22227247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The SNON-SMAD4 complex binds the SKIL gene promoter via a TGF-β response element (containing SMAD-binding elements) and negatively regulates basal SKIL gene expression by recruiting histone deacetylases, forming a negative feedback loop. Upon TGF-β signaling, SNON is removed from the promoter, allowing activated SMAD complexes to induce SKIL expression.\",\n      \"method\": \"ChIP, sequential ChIP, promoter cloning, luciferase reporter assay, HDAC recruitment assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — ChIP plus sequential ChIP showing SNON-SMAD4 occupancy, functional reporter assay with multiple methods in single lab\",\n      \"pmids\": [\"22674574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In human embryonic stem cells, SNON predominantly associates with SMAD2 at the promoters of primitive streak and early definitive endoderm marker genes to repress them. SNON knockdown causes premature activation of PS and DE genes and loss of hESC morphology; enforced SNON expression inhibits DE formation and diverts hESCs toward extraembryonic fate.\",\n      \"method\": \"ChIP, RNAi knockdown, overexpression, gene expression analysis\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP demonstrating promoter occupancy, reciprocal gain/loss of function with clear developmental phenotypes\",\n      \"pmids\": [\"23154981\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SnoN promotes Stat5 stability and signaling in mammary epithelial cells. SnoN expression is induced at late pregnancy by coordinated TGF-β and prolactin actions. SnoN-/- mice show severe alveologenesis and lactogenesis defects rescued by active Stat5, placing SnoN upstream of Stat5 in a TGF-β/prolactin-coordinating pathway.\",\n      \"method\": \"Knockout mouse model, rescue experiment with active Stat5, co-immunoprecipitation, Stat5 stability assay\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with in vivo phenotype, rescue experiment establishing epistasis, Co-IP\",\n      \"pmids\": [\"22833129\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SnoN suppresses BMP signaling (ID1 expression) in chondrocytes in a TGF-β-induced manner downstream of Smad2 phosphorylation, but upstream of BMP-regulated Smad1/5/8 activation; this mediates TGF-β cross-inhibition of BMP-driven hypertrophic chondrocyte maturation (Col10a1 expression).\",\n      \"method\": \"siRNA knockdown, overexpression, luciferase reporter assay, pharmacological inhibitor (SB431542)\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain and loss of function with pathway placement, single lab\",\n      \"pmids\": [\"22767605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SnoN directly binds to ALK1 on the plasma membrane in endothelial cells and facilitates the interaction between ALK1 and Smad1/5, enhancing Smad1/5 phosphorylation and promoting angiogenesis. Disruption of the SnoN-Smad interaction impairs Smad1/5 activation, up-regulates Smad2/3 activity, causes arteriovenous malformations, and leads to embryonic lethality at E12.5.\",\n      \"method\": \"Co-immunoprecipitation, mutagenesis, conditional knockout mouse model, phospho-Smad assays\",\n      \"journal\": \"Journal of Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — endogenous protein Co-IP, mutagenesis, in vivo KO with defined vascular phenotype and epistasis\",\n      \"pmids\": [\"24019535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"SnoN interacts with multiple components of the Hippo pathway and inhibits the binding of Lats2 to TAZ, preventing TAZ phosphorylation and promoting TAZ stabilization. SnoN enhances transcriptional and oncogenic activities of TAZ; reducing SnoN decreases TAZ expression. SnoN itself is downregulated by Lats2 activated by the Scribble polarity protein.\",\n      \"method\": \"Co-immunoprecipitation, kinase assay, knockdown/overexpression, TAZ phosphorylation assay\",\n      \"journal\": \"Developmental Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, kinase-substrate relationship, bidirectional regulatory relationship established\",\n      \"pmids\": [\"27237790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Crystal structure of the SAND domain of SnoN in complex with the MH2 domain of SMAD4 was determined, showing a binding mode compatible with simultaneous coordination of R-SMADs. SnoN forms a stable complex with SMAD3 and SMAD4, and this complex formation is distinct from Ski, which disrupts R-SMAD/Co-SMAD heteromers.\",\n      \"method\": \"X-ray crystallography, biochemical co-purification, stability assay\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with functional validation, single lab\",\n      \"pmids\": [\"28397834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Crystal structure of the Dachshund homology domain of human SnoN was determined, revealing a conserved groove with properties of a protein-interaction surface showing conformational flexibility (open and tight conformations), suggesting SnoN can recognize multiple interaction partners.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"PLoS One\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — crystal structure without biochemical or mutagenesis functional validation of the groove\",\n      \"pmids\": [\"20957027\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SnoN promotes mesenchymal stem cell differentiation into the adipocyte lineage by antagonizing activin A/Smad2 (but not TGF-β/Smad3) signaling. Mice lacking SnoN or expressing a SnoN mutant defective in Smad binding are protected from high-fat diet-induced obesity. SnoN represses activin A expression through an autocrine mechanism in adipocytes.\",\n      \"method\": \"Conditional knockout mouse, high-fat diet model, MSC differentiation assay, Smad-binding mutant\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo KO with specific phenotype, mutagenesis establishing Smad-binding requirement, pathway specificity defined\",\n      \"pmids\": [\"30030373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Conditional knockout of SnoN in cerebellar granule neuron precursors inhibits their proliferation and promotes cell cycle exit at later postnatal stages. SnoN promotes expression of cell proliferation genes and represses differentiation genes in vivo. SnoN physically interacts with N-myc and Pax6 transcription factors.\",\n      \"method\": \"Conditional KO, laser capture microdissection/RNA-Seq, Co-immunoprecipitation, behavioral analysis\",\n      \"journal\": \"Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with genomic profiling and Co-IP identifying novel interaction partners, in vivo behavioral phenotype\",\n      \"pmids\": [\"30425119\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Quantitative ubiquitylome proteomics established that RNF111/Arkadia E3 ubiquitin ligase specifically ubiquitylates SKI and SKIL/SnoN (and no other substrates) upon TGF-β activation. Lysine 343 within the SAND domain of SKIL is identified as the principal ubiquitylation site targeted by RNF111.\",\n      \"method\": \"Quantitative ubiquitylome mass spectrometry (diGly remnant immunoprecipitation, ubiquitin nanobody IP), CRISPR-engineered cell lines\",\n      \"journal\": \"Molecular & Cellular Proteomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — quantitative proteomics with two independent enrichment methods and CRISPR controls, identifies specific ubiquitylation site\",\n      \"pmids\": [\"34740826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Arkadia inactivation in CD4+ T cells impairs iTreg differentiation in vitro and in vivo. Genetic ablation of both SKI and SnoN rescues Arkadia-deficient iTreg cell differentiation, establishing that Arkadia promotes iTreg differentiation by targeting SKI/SnoN for degradation. Arkadia is dispensable for Th17 cell responses.\",\n      \"method\": \"Conditional KO, double KO rescue/epistasis, flow cytometry, in vivo gut inflammation model\",\n      \"journal\": \"Journal of Experimental Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with double KO rescue in vivo, clear pathway placement\",\n      \"pmids\": [\"34473197\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PIAS1 and TIF1γ form a trimeric complex with SnoN and collaborate in an interdependent manner to promote SnoN SUMOylation, leading to suppression of EMT in mammary epithelial organoids. Loss of PIAS1 and TIF1γ shows cooperative requirement for EMT suppression.\",\n      \"method\": \"Co-immunoprecipitation, in vivo SUMOylation assay, loss-of-function in 3D organoids\",\n      \"journal\": \"Cell Death and Differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — trimeric complex Co-IP, functional SUMOylation assay, 3D organoid phenotype\",\n      \"pmids\": [\"32770107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Sumoylation promotes the interaction of SnoN with HDAC1 and p300. HDAC1 suppresses, whereas p300 promotes, TGF-β-induced EMT-associated changes in 3D mammary organoids. Sumoylated SnoN modulates EMT via regulation of histone acetylation.\",\n      \"method\": \"Co-immunoprecipitation, gain/loss-of-function, 3D mammary organoid assay, histone acetylation analysis\",\n      \"journal\": \"Cell Death & Disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, functional organoid assay, single lab\",\n      \"pmids\": [\"37414747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GnRH pulse frequency differentially regulates SKIL (SnoN) expression in gonadotrope cells, where SnoN functions as a corepressor of the FSHβ promoter. Overexpression of Smad-binding or phosphorylation-defective SKIL mutants fails to repress FSHβ promoter activity; SKIL knockdown increases FSHβ promoter activity. ChIP shows FOS and SKIL occupy the FSHβ promoter cyclically after GnRH stimulation.\",\n      \"method\": \"ChIP, transfection reporter assay, siRNA knockdown, dominant-negative mutant analysis\",\n      \"journal\": \"Molecular Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus functional reporter and knockdown, single lab\",\n      \"pmids\": [\"21659477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SnoN binds the smad7 gene promoter at basal conditions and represses it. After short TGF-β treatment, SnoN is downregulated and leaves the promoter; after prolonged TGF-β treatment, upregulated SnoN returns to the smad7 promoter, functioning as a negative feedback control.\",\n      \"method\": \"Chromatin immunoprecipitation, transcriptional reporter assay\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct promoter binding with temporal dynamics, single lab\",\n      \"pmids\": [\"16442497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The C-terminal third of c-Ski mediates stable homodimerization with itself and heterodimerization with SnoN. Two structural motifs constitute the dimerization domain: a domain of five tandem 25-amino-acid repeats required for dimerization, and a predicted leucine zipper that enhances dimerization. c-Ski forms heterodimers with SnoN that are detectable by cross-linking of native protein.\",\n      \"method\": \"In vitro translated protein cross-linking, bacterial fusion protein pulldown, deletion analysis\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro interaction mapping with deletion analysis, single lab, consistent with later studies\",\n      \"pmids\": [\"7929440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"SnoN binds a specific DNA sequence (GTCTAGAC) and represses transcription through a tripartite repression domain. One subdomain of SnoN interacts with TAF(II)110 as part of a quenching mechanism of transcriptional repression. Two of the three repression subdomains are required for both DNA binding and cellular transformation.\",\n      \"method\": \"Transcriptional reporter assay, Gal4 fusion assay, deletion mutagenesis, transformation assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic domain analysis with functional readouts, single lab\",\n      \"pmids\": [\"9824161\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"c-Ski and SnoN preferentially form heterodimers over homodimers when co-expressed. Tethered Ski:Sno heterodimers lacking TR/LZ domains are more active than monomeric counterparts or tethered homodimers in transcriptional repression and cellular transformation.\",\n      \"method\": \"In vitro transcription/translation co-expression, DNA binding assay, transformation assay, tethered dimer constructs\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo dimerization assays with functional consequence, single lab\",\n      \"pmids\": [\"9927733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"c-Ski and SnoN bind to the 'SE' sequence in the C-terminal MH2 domain of Smad3, with 'QPSMT' sequence nearby supporting the interaction. Similar sequences exist in Smad2 but not Smad1, explaining preferential binding. Smurf2 is located close to SnoN via binding to the linker region of Smad2, enabling ubiquitin-dependent degradation of SnoN.\",\n      \"method\": \"Mutagenesis, binding assays, structural analysis of Smad3 MH2 domain\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic mutagenesis defining binding interface, single lab\",\n      \"pmids\": [\"12426322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NSUN2 RNA methyltransferase induces m5C modification of SKIL mRNA, stabilizing it via Y-box binding protein 1 (YBX1)-mediated recognition. Elevated SKIL levels in turn increase TAZ transcriptional coactivator activation, promoting colorectal cancer progression.\",\n      \"method\": \"m5C-methylated RNA immunoprecipitation, RNA stability assay, NSUN2 knockout mouse, siRNA knockdown, Co-immunoprecipitation\",\n      \"journal\": \"Clinical and Translational Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct m5C modification demonstrated biochemically with functional mRNA stability readout, single lab\",\n      \"pmids\": [\"38468490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SKIL (SnoN) overexpression induces cell invasion in immortalized human mammary epithelial cells, and SKIL induces invasion through upregulation of SLUG (SNAI2) expression. Co-expression of TLOC1 and SKIL induces subcutaneous tumor growth in vivo.\",\n      \"method\": \"Gain-of-function genetic screen, invasion assay, gene expression analysis, xenograft tumor assay\",\n      \"journal\": \"Cancer Discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional genetic screen with defined molecular mechanism (SLUG upregulation), in vivo xenograft\",\n      \"pmids\": [\"23764425\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SKIL/SnoN is a nuclear and cytoplasmic transcriptional coregulator that negatively modulates TGF-β/Smad signaling by directly binding Smad2, Smad3, and Smad4 to repress target gene transcription via recruitment of N-CoR, HDACs, and disruption of Smad complexes; it is subject to rapid, signal-induced ubiquitin-proteasomal degradation mediated by at least three distinct E3 ubiquitin ligase complexes (Smad3-APC/Cdh1, Smad2-Smurf2, and Arkadia/RNF111), with Arkadia ubiquitylating SnoN specifically at K343 of its SAND domain; SnoN is also post-translationally modified by SUMOylation (at K50/K383, via PIAS1/TIF1γ) which promotes promoter-specific transcriptional repression and suppression of EMT through recruitment of HDAC1/p300; beyond TGF-β, SnoN intersects the Hippo pathway by inhibiting Lats2-mediated TAZ phosphorylation, promotes ALK1-Smad1/5 angiogenic signaling, interacts with PML to stabilize p53 and induce senescence, interacts with ERα to enhance estrogen-dependent transcription, and in neurons drives axonal morphogenesis through a Smad2-SnoN-Ccd1-JNK pathway and granule neuron precursor proliferation through interactions with N-myc and Pax6.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SKIL (SnoN) is a transcriptional coregulator that functions as a central negative-feedback node of the TGF-β/Smad pathway, directly binding Smad2, Smad3, and Smad4 to repress TGF-β-responsive genes in the absence of ligand through recruitment of the N-CoR corepressor and histone deacetylases [#0, #1, #5]. Repression requires intact Smad-binding regions, and this same activity underlies its oncogenic transforming potential, linking Smad antagonism directly to transformation [#5]. Structural work shows the SnoN SAND domain engages the SMAD4 MH2 domain in a manner compatible with simultaneous coordination of R-Smads, forming a stable Smad3–Smad4–SnoN complex [#23]. SnoN itself is subject to tightly controlled signal-induced destruction: TGF-β triggers its rapid ubiquitin-proteasomal degradation through at least three distinct E3 ligase routes — a Smad3-recruited APC/CDH1 complex acting on a destruction box, a Smad2–Smurf2 complex, and Arkadia/RNF111, which ubiquitylates SnoN specifically at K343 in the SAND domain only when complexed with phosphorylated Smad2/3 [#3, #4, #2, #9, #27]. This degradation, augmented by TAK1-mediated phosphorylation, transiently relieves repression before SnoN re-expression re-establishes feedback control [#3, #9]. SnoN is also SUMOylated at K50/K383 via PIAS1/TIF1γ, a modification that promotes promoter-specific repression and suppresses EMT through HDAC1/p300 recruitment without altering protein stability [#8, #11, #29, #30]. Beyond canonical TGF-β control, SnoN integrates additional signaling axes: it inhibits Lats2-mediated TAZ phosphorylation to stabilize TAZ in the Hippo pathway [#22], binds ALK1 to promote Smad1/5 angiogenic signaling [#21], and engages PML to stabilize p53 and induce senescence as a Smad-independent tumor-suppressive program [#14]. In vivo it controls cerebellar granule neuron precursor proliferation and axonal morphogenesis via a Smad2–SnoN–Ccd1–JNK pathway and interactions with N-myc and Pax6 [#7, #12, #13, #26], and governs developmental and tissue-specific fates including endoderm specification, mammary alveologenesis through Stat5, and adipocyte differentiation [#18, #19, #25].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established SnoN as a direct negative regulator of TGF-β signaling, answering how Smad transcriptional output is held off in the basal state and reset after stimulation.\",\n      \"evidence\": \"Co-IP, reporter assays, and proteasome inhibition showing SnoN-Smad2/3/4 binding, N-CoR recruitment, and TGF-β-induced degradation with delayed re-expression\",\n      \"pmids\": [\"10531062\", \"10535941\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism coupling Smad nuclear accumulation to SnoN turnover not yet defined\", \"Promoter-level chromatin events not resolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defined the E3 ligase machinery for signal-induced SnoN destruction, explaining how TGF-β rapidly clears the repressor to permit gene activation.\",\n      \"evidence\": \"In vitro ubiquitination reconstitution, Co-IP, and mutagenesis identifying Smad3-recruited APC/CDH1 (D-box dependent) and Smad2–Smurf2 complexes\",\n      \"pmids\": [\"11389444\", \"11691834\", \"11741538\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of each ligase in different cell types unresolved\", \"Did not yet identify all ubiquitin acceptor lysines\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Mapped the molecular interface for Smad recognition, explaining preferential binding to Smad2/3 over Smad1 and positioning of the degradation machinery.\",\n      \"evidence\": \"Mutagenesis and binding assays defining the SE/QPSMT sequences in the Smad3 MH2 domain and Smurf2 docking on the Smad2 linker\",\n      \"pmids\": [\"12426322\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural detail of the interface not yet available at this stage\", \"Single lab\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Linked SnoN's Smad-repression function causally to its transforming activity, distinguishing the two binding regions required for antagonism.\",\n      \"evidence\": \"Systematic mutagenesis with reporter, cell-cycle, and transformation assays showing both Smad-binding regions are needed for repression and transformation\",\n      \"pmids\": [\"12764135\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream transforming target genes not defined here\", \"Single lab\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Revealed that SnoN can act in the cytoplasm by Smad sequestration, distinguishing nuclear repression from cytoplasmic antagonism and tying localization to cell state.\",\n      \"evidence\": \"Subcellular fractionation, immunofluorescence, and functional TGF-β assays across cell types\",\n      \"pmids\": [\"16109768\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals controlling nuclear-cytoplasmic shuttling not defined\", \"Determinants of cytoplasmic degradation resistance unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified Arkadia/RNF111 and uncovered SnoN's distinct neuronal role, broadening both its degradation control and its biological functions.\",\n      \"evidence\": \"siRNA screen, Co-IP, ubiquitination assays for Arkadia; reciprocal Co-IP, RNAi, and in vivo cerebellar electroporation for axonal growth; ChIP for smad7 promoter feedback\",\n      \"pmids\": [\"17591695\", \"17510063\", \"16675394\", \"16442497\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Arkadia substrate selectivity is achieved not yet resolved\", \"Neuronal transcriptional targets not yet identified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Established SUMOylation as a regulatory layer controlling promoter-specific repression independent of stability.\",\n      \"evidence\": \"In vivo SUMOylation assays, K50R/K383R mutagenesis, Ubc9/PIAS1 dependence, and myogenin/muscle gene readouts\",\n      \"pmids\": [\"16966324\", \"17202138\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which SUMO alters promoter selectivity unresolved\", \"Genome-wide SUMO-dependent target set undefined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Ordered the neuronal pathway, placing Smad2 upstream of SnoN in Cdh1-APC-controlled axonal morphogenesis.\",\n      \"evidence\": \"Endogenous Co-IP, RNAi, and genetic epistasis with axon-length measurement\",\n      \"pmids\": [\"18287512\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream effectors not yet identified at this step\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined effector arms of SnoN function: a Ccd1-JNK axon-growth program and a Smad-independent PML/p53 senescence and tumor-suppressor program.\",\n      \"evidence\": \"Co-IP, gene profiling, in vivo electroporation for p300/Ccd1; Co-IP, PML body IF, p53 stability, and in vivo carcinogenesis for senescence\",\n      \"pmids\": [\"19339625\", \"19745809\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Switch between oncogenic and tumor-suppressive outputs not mechanistically defined\", \"Threshold of SnoN level dictating senescence unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Provided the first structural view of a SnoN interaction domain, revealing conformational flexibility consistent with multipartner recognition.\",\n      \"evidence\": \"X-ray crystallography of the Dachshund homology domain\",\n      \"pmids\": [\"20957027\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Crystal structure lacks biochemical/mutagenesis validation of the groove\", \"Specific partners engaging the groove not tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrated direct promoter occupancy and a self-regulating feedback loop, and expanded SnoN's targets to developmental and tissue-specific programs.\",\n      \"evidence\": \"ChIP/sequential ChIP on SKIL and developmental promoters, reporter assays, gain/loss of function in hESCs, KO mouse rescue with Stat5, and BMP cross-inhibition assays\",\n      \"pmids\": [\"22674574\", \"23154981\", \"22833129\", \"20457602\", \"22767605\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide direct binding map incomplete\", \"Coregulator switching at distinct promoters not fully defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Extended SnoN's corepressor function to ERα-enhanced and GnRH-regulated transcription, showing context-dependent coactivator and corepressor roles.\",\n      \"evidence\": \"Co-IP, LxxLL mutagenesis, ChIP and reporter assays for ERα; ChIP, reporter and knockdown for FSHβ promoter\",\n      \"pmids\": [\"22227247\", \"21659477\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic basis for coactivator versus corepressor switching unresolved\", \"Single lab for each context\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined oncogenic outputs of SnoN amplification, linking it to invasion via SLUG and to tumor growth.\",\n      \"evidence\": \"Gain-of-function screen, invasion assays, expression analysis, and xenograft tumor assay\",\n      \"pmids\": [\"23764425\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct versus indirect regulation of SLUG not resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Connected SnoN to the Hippo pathway, showing it stabilizes TAZ by blocking Lats2 and is reciprocally regulated by Lats2/Scribble.\",\n      \"evidence\": \"Reciprocal Co-IP, kinase assays, and knockdown/overexpression with TAZ phosphorylation readout\",\n      \"pmids\": [\"27237790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Lats2-TAZ disruption undefined\", \"Integration with TGF-β SnoN pool unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Provided structural and biochemical definition of the SnoN-SMAD4 complex, distinguishing SnoN's stable-complex mode from Ski's heteromer-disrupting mode.\",\n      \"evidence\": \"X-ray crystallography of the SAND domain–SMAD4 MH2 complex with co-purification and stability assays\",\n      \"pmids\": [\"28397834\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of full Smad3-Smad4-SnoN assembly not determined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Established pathway-selective in vivo functions, separating activin-A/Smad2 from TGF-β/Smad3 outputs in adipogenesis and defining granule neuron precursor proliferation control.\",\n      \"evidence\": \"Conditional KO and Smad-binding mutant mice with metabolic phenotype; conditional KO with RNA-Seq and Co-IP identifying N-myc/Pax6\",\n      \"pmids\": [\"30030373\", \"30425119\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Basis for Smad2 versus Smad3 selectivity not mechanistically resolved\", \"Direct N-myc/Pax6 target genes undefined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined the SUMO E3 machinery and its consequence, showing PIAS1/TIF1γ cooperate to SUMOylate SnoN and suppress EMT.\",\n      \"evidence\": \"Co-IP, in vivo SUMOylation assays, and loss-of-function in 3D organoids\",\n      \"pmids\": [\"32770107\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interdependence mechanism of PIAS1/TIF1γ not fully resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Resolved Arkadia's substrate specificity at proteome scale and demonstrated its physiological role in iTreg differentiation through SKI/SnoN degradation.\",\n      \"evidence\": \"Quantitative ubiquitylome MS with CRISPR controls identifying K343; conditional and double-KO epistasis in T cells with in vivo gut inflammation model\",\n      \"pmids\": [\"34740826\", \"34473197\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How RNF111 restricts itself to SKI/SnoN not structurally defined\", \"Role of K343 ubiquitylation in non-immune contexts not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed SUMOylation directs SnoN's coregulator partner choice between HDAC1 and p300 to tune EMT-associated histone acetylation.\",\n      \"evidence\": \"Co-IP, gain/loss-of-function, and histone acetylation analysis in 3D mammary organoids\",\n      \"pmids\": [\"37414747\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Promoter-level acetylation changes not mapped genome-wide\", \"Single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified upstream RNA-level control of SKIL via m5C methylation, linking transcript stabilization to TAZ activation in cancer.\",\n      \"evidence\": \"m5C-meRIP, RNA stability assays, NSUN2 KO mouse, and Co-IP\",\n      \"pmids\": [\"38468490\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality across tissues of m5C control unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How SnoN switches between tumor-suppressive (PML/p53 senescence, Smad repression) and oncogenic (TAZ stabilization, SLUG-driven invasion) outputs in a given cellular context remains undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No unifying model linking SnoN level, modification state, and context to functional output\", \"Genome-wide direct binding and coregulator-switching map incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 5, 17, 18, 34]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [34, 35]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 21, 22, 19]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2, 9, 21]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [37]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1, 6, 16]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [21]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [14, 18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 9, 21, 22]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 17, 18, 34]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [2, 3, 9, 27]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [18, 19, 25, 26]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [28]}\n    ],\n    \"complexes\": [\n      \"Smad3-Smad4-SnoN repressor complex\",\n      \"Smad3-APC/CDH1 ubiquitin ligase complex\",\n      \"Smad2-Smurf2 ubiquitin ligase complex\",\n      \"PIAS1-TIF1γ-SnoN SUMOylation complex\"\n    ],\n    \"partners\": [\n      \"SMAD2\",\n      \"SMAD3\",\n      \"SMAD4\",\n      \"RNF111\",\n      \"SMURF2\",\n      \"PIAS1\",\n      \"TAZ\",\n      \"ALK1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}